‘Acute Respiratory Distress Syndrome (ARDS)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Acute Respiratory Distress Syndrome (ARDS) epidemiology in the United States, EU5 (Germany, France, Italy, and United Kingdom), and Japan.
Geographies Covered • The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Study Period: 2017–2030
Acute Respiratory Distress Syndrome (ARDS) Understanding Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients. The main complication in ARDS is that fluid leaks into the lungs, making breathing difficult or impossible. Acute lung injury (ALI) is a common condition characterized by acute severe hypoxia that is not due to left atrial hypertension. The term ALI encompasses a continuum of clinical and radiographic changes that affect the lungs with the acute respiratory distress syndrome (ARDS) representing the more severe end of this continuum. Despite advances in the understanding of the pathophysiology and management of ALI, it is still associated with high mortality.
The causes of ARDS are divided into two categories: direct or indirect injuries to the lung. Some of the direct injuries to the lung include pneumonia, aspiration, trauma, and others whereas the indirect injuries to the lung include inflammation of the pancreas, severe infection (also known as sepsis), blood transfusions, burns, and medication reactions. The few symptoms of ARDS are shortness of breath, cough, and fever. In some cases, those with ARDS also have fast heart rates and rapid breathing. Occasionally, patients of ARDS experience chest pain, especially during inhalation. Some patients also experience bluish coloring of nails and lips due to the severely decreased oxygen levels in the blood. There are several risks factors that may escalate the risk for ARDS; this involves obesity, alcohol abuse, chemotherapy, low-protein in blood.
A novel strain of coronavirus emerged in December 2019, which was termed as COVID-19 by the World Health Organization (WHO). Coronaviruses belong to a family of viruses that range from the common cold to MERS coronavirus, which is Middle East Respiratory Syndrome and Severe acute respiratory syndrome (SARS) coronavirus. The clinical data of COVID-19 severely infected patients suggest that radiologic evidence of lung edema— a manifestation of ALI and may progress to hypoxemia and potentially ARDS—is common. The occurrence and severity of ALI are a major determining factor of the prognosis of patients with COVID?19 infection. About 30% of patients with COVID?19 infection in the ICU developed severe lung edema, dyspnea, hypoxemia, or even ARDS. COVID-19 patients diagnosed with ARDS have a poor prognosis and high mortality.
Acute Respiratory Distress Syndrome (ARDS) Epidemiology Perspective The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Population of ARDS, Severity-specific Incidence of ARDS, and Incidence of ARDS by Risk Factors scenario of Acute Respiratory Distress Syndrome (ARDS) in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.
Acute Respiratory Distress Syndrome (ARDS) Detailed Epidemiology Segmentation • In the 7MM, the total incident population of ARDS is estimated to be 799,872, in 2017.
• Generally, the highest number of incident cases were assessed for ARDS due to Pneumonia, in all the 7MM countries, except the United Kingdom, in which Sepsis was the primary risk factor for ARDS.
• Due to occurrence of COVID-19, there is a sudden increase in the cases of ARDS in the US, from 495,655 in 2017, to 550,371 in 2020.
• Among the EU-5 countries, Germany had the highest incident population of ARDS with 148,302 cases, followed by Italy, with 44,700 cases, in 2017. On the other hand, Spain had the lowest incident population of 20,839 in 2017. Besides, Japan had 19,137 incident cases of ARDS in 2017.
Scope of the Report • The report covers the descriptive overview of Acute Respiratory Distress Syndrome (ARDS), explaining its causes, signs and symptoms, pathophysiology and currently available therapies.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of Acute Respiratory Distress Syndrome (ARDS).
• The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Acute Respiratory Distress Syndrome (ARDS), Total Diagnosed and Treated Cases of Acute Respiratory Distress Syndrome (ARDS).
Report Highlights • Eleven-Year Forecast of Acute Respiratory Distress Syndrome (ARDS)
• 7MM Coverage
• Total Incident Population of ARDS
• Severity-specific Incidence of ARDS
• Incidence of ARDS by Risk Factors
• Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM is estimated to increase during the forecasted period (2020–2030).
• Severity-specific Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM is projected to rise during the study period (2017–2030)
Key Questions Answered • What is the disease risk, burden and unmet needs of Acute Respiratory Distress Syndrome (ARDS)?
• What is the historical Acute Respiratory Distress Syndrome (ARDS) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
• What would be the forecasted patient pool of Acute Respiratory Distress Syndrome (ARDS) at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Acute Respiratory Distress Syndrome (ARDS)?
• Out of the countries mentioned above, which country would have the highest prevalent population of Acute Respiratory Distress Syndrome (ARDS) during the forecast period (2020–2030)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2020–2030)?
Reasons to buy The Acute Respiratory Distress Syndrome (ARDS) report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the 7MM Acute Respiratory Distress Syndrome (ARDS) market.
• Quantify patient populations in the 7MM Acute Respiratory Distress Syndrome (ARDS) market to improve product design, pricing, and launch plans.
• The Acute Respiratory Distress Syndrome (ARDS) epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Acute Respiratory Distress Syndrome (ARDS) epidemiology model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.
Key Assessments • Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population
Our reports have been used by over 10K customers, including:
No air: Demand for industry services has declined as a result of the closure of nonessential businesses Abstract Air Duct Cleaning Services in the US Operators in this industry provide air duct cleaning services to buildings and dwellings. This includes the cleaning of heating and cooling system components. This...
Abstract Technical Support & Help Desk Services Procurement in the US This report is intended to assist buyers of technical support and help desk services. Technical support and help desk service providers field questions and incoming calls from customers in need of assistance with product or service features....
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
Abstract Fleet Telematics Systems Procurement in the US This report is intended to assist buyers of fleet telematics systems. Fleet telematics systems are used to monitor, map and track vehicle fleets in the field. Digital maps and Global Positioning System (GPS) technology allow for real-time visualization...
Step by step: An aging US population and a rising prevalence of diabetes are expected to boost industry demand Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and the...
Abstract Industrial Absorbents Procurement in the US This report is intended to aid buyers of industrial absorbents, which are commonly used by construction and manufacturing firms as well as natural gas and oil producers to contain and clean spills. Common types of market products include granular absorbents,...
Transforming Growth Factor Beta 1 - Pipeline Review, H2 2020
Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor beta 1 (TGF-?1) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by the TGFB1 gene. It plays an important role...
Pulmonary Arterial Hypertension - Global Drug Forecast and Market Analysis to 2029
Pulmonary arterial hypertension is a rare, fatal cardiopulmonary disease with an annual mortality rate around 10%.The disease is a subset (Group 1) within the World Health Organization’s (WHO’s) classification...
Impact of COVID-19 on the Top Five European Soccer Leagues
Analysis of the impact COVID-19 has had on the top five European Soccer leagues
Economic analysis on the cost of postponing domestic cup fixtures, including ticket prices and estimated losses.
Anatomic pathology track and trace solutions market projected to grow at a CAGR of 10.4% The anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4% from 2018 to 2023. The increasing volume of diagnostic tests performed in anatomic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.